0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Research Letter | 
Terri Voepel-Lewis, PhD; Deborah Wagner, PharmD; Alan R. Tait, PhD
JAMA Pediatr. 2015;169(5):497-498. doi:10.1001/jamapediatrics.2014.3583.

Editorial | 
Robert Williams, MD; Robert Pfister, MD; Ian Black, MD
JAMA Pediatr. 2014;168(8):701-703. doi:10.1001/jamapediatrics.2014.469.

Original Investigation | 
Frank H. Morriss Jr, MD, MPH; Shampa Saha, PhD; Edward F. Bell, MD; et al.
JAMA Pediatr. 2014;168(8):746-754. doi:10.1001/jamapediatrics.2014.307.
Includes: CME, Supplemental Content

Original Investigation | 
Jianghong Liu, PhD; Xianchen Liu, MD, PhD; Wei Wang, PhD; et al.
JAMA Pediatr. 2014;168(8):737-745. doi:10.1001/jamapediatrics.2014.332.
Includes: Supplemental Content

Editorial | 
Shanna H. Swan, PhD
JAMA Pediatr. 2014;168(1):14-15. doi:10.1001/jamapediatrics.2013.4215.

Original Investigation |  FREE
Kelly K. Ferguson, MPH; Thomas F. McElrath, MD, PhD; John D. Meeker, ScD
JAMA Pediatr. 2014;168(1):61-68. doi:10.1001/jamapediatrics.2013.3699.
Includes: Supplemental Content

JAMA Pediatrics Patient Page |  FREE
Megan Moreno, MD, MSEd, MPH
JAMA Pediatr. 2014;168(1):96. doi:10.1001/jamapediatrics.2013.3319.

Original Investigation |  FREE
Pranita D. Tamma, MD, MHS; Alison E. Turnbull, DVM, MPH; Anthony D. Harris, MD, MPH; et al.
JAMA Pediatr. 2013;167(10):903-910. doi:10.1001/jamapediatrics.2013.196.

Original Investigation |  FREE
George Sam Wang, MD; Genie Roosevelt, MD, MPH; Kennon Heard, MD
JAMA Pediatr. 2013;167(7):630-633. doi:10.1001/jamapediatrics.2013.140.

Editorial | 
William Hurley, MD; Suzan Mazor, MD
JAMA Pediatr. 2013;167(7):602-603. doi:10.1001/jamapediatrics.2013.2273.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index
Elisa V. Bandera, MD, PhD; Valerie S. Lee, MHS; Lorna Rodriguez-Rodriguez, MD, PhD; et al.
JAMA Oncology
Brief Report  | 
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib
Kenar D. Jhaveri, MD; Vipulbhai Sakhiya, MBBS; Steven Fishbane, MD
JAMA Oncology
Invited Commentary  | 
JAK/STAT Pathway Inhibitors and Neurologic Toxicity: Above All Else Do No Harm?
Bart L. Scott, MD; Pamela S. Becker, MD, PhD
JAMA Oncology
Original Investigation  | 
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial
Animesh Pardanani, MD; Claire Harrison, MD; Jorge E. Cortes, MD; et al.